454126 Methotrexate - CAS 59-05-2 - Calbiochem

Methotrexate - CAS 59-05-2 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
454126
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₂₀H₂₂N₈O₅ • 3H₂O 59-05-2

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
454126-100MG
Retrieving availability...
—
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Glass bottle 100 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewInhibits thymidylate synthetase, is a nonselective de novo purine synthesis inhibitor, and has a significant toxicity profile including hepatotoxicity, pneumonitis, and bone marrow suppression. Potent folic acid antagonist. Induces apoptosis in HL-60 human leukemia cells. Also useful as an antitumor agent.
      Catalogue Number454126
      Brand Family Calbiochem®
      References
      ReferencesKaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
      Takasuga, A., et al. 1992. J. Biochem. 112, 652.
      Hirata, S., et al. 1989. Arthritis Rheum. 32, 1065.
      Jolivet, J., et al. 1983. New Engl. J. Med. 309, 1094.
      Product Information
      CAS number59-05-2
      FormYellow solid
      Hill FormulaC₂₀H₂₂N₈O₅ • 3H₂O
      Chemical formulaC₂₀H₂₂N₈O₅ • 3H₂O
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 23/24/25-36/37/38-45-46

      Toxic by inhalation, in contact with skin and if swallowed.
      Irritating to eyes, respiratory system and skin.
      May cause cancer.
      May cause heritable genetic damage.
      S PhraseS: 22-24/25-36/37/39

      Do not breathe dust.
      Avoid contact with skin and eyes.
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Toxic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Methotrexate - CAS 59-05-2 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Methotrexate - CAS 59-05-2 - Calbiochem Certificates of Analysis

      TitleLot Number
      454126

      References

      Reference overview
      Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
      Takasuga, A., et al. 1992. J. Biochem. 112, 652.
      Hirata, S., et al. 1989. Arthritis Rheum. 32, 1065.
      Jolivet, J., et al. 1983. New Engl. J. Med. 309, 1094.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision13-October-2010 RFH
      DescriptionInhibits thymidylate synthetase, is a nonselective de novo purine synthesis inhibitor and has a significant toxicity profile including hepatotoxicity, pneumonitis and bone marrow suppression. Potent folic acid antagonist. Induces apoptosis in HL-60 human leukemia cells. Also useful as an anti-tumor agent.
      FormYellow solid
      CAS number59-05-2
      Chemical formulaC₂₀H₂₂N₈O₅ • 3H₂O
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Toxic
      Merck USA index14, 5985
      ReferencesKaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
      Takasuga, A., et al. 1992. J. Biochem. 112, 652.
      Hirata, S., et al. 1989. Arthritis Rheum. 32, 1065.
      Jolivet, J., et al. 1983. New Engl. J. Med. 309, 1094.